Federal Circuit / U.S. Court of Spec. Jurisdiction

Published between:
Published Title Organization
Nov
17
2020
 Prosecution Guidance from the Fed. Cir. – How to Forfeit Arguments During Your Appeal Schwegman, Lundberg & Woessner, P.A.
Nov
13
2020
 C. R. Bard v. Angiodynamics – It’s a Labelled Injection Port, not a Label Schwegman, Lundberg & Woessner, P.A.
Nov
11
2020
 Federal Circuit Will Not Second-Guess IPR Institution Denials McDermott Will & Emery
Nov
11
2020
 Venue in Hatch-Waxman Cases Limited to District Where ANDA Is Submitted McDermott Will & Emery
Nov
10
2020
 Federal Circuit Limits Venue In ANDA Litigation Foley & Lardner LLP
Nov
9
2020
 Immunex v. Sanofi-Aventis – The “Mystery Dance” of Claim Construction Schwegman, Lundberg & Woessner, P.A.
Nov
6
2020
 Federal Circuit Limits Venue for Hatch-Waxman Cases Polsinelli PC
Nov
4
2020
 Too Good to Be True? Federal Circuit Demands Evidence of Reliance on Favorable Ruling, Stipulation McDermott Will & Emery
Nov
4
2020
 No Stay, But Please Fix McDermott Will & Emery
Nov
4
2020
 First-to-File Rule Must Be Followed Unless Compelling Circumstances Justify Exception McDermott Will & Emery
Nov
4
2020
 Trademark Cancellation Is Appropriate Sanction for Misconduct McDermott Will & Emery
Nov
2
2020
 Skinny Label Doesn’t Prevent Infringement Liability Foley & Lardner LLP
Oct
29
2020
 Size Matters in Obviousness Analysis McDermott Will & Emery
Oct
27
2020
 Patent Infringement Pleading Standards Remain Unsettled Five Years After the Abrogation of Form 18 – Part 1: Inconsistent Federal Circuit Guidance Sheppard, Mullin, Richter & Hampton LLP
Oct
22
2020
 Only Human: Broadest Reasonable Interpretation Standard Applies to Intentionally Expired Patent McDermott Will & Emery
Oct
22
2020
 Define Frustration: Appealing from Decision in Suit Against Co-Owner’s Wholly Owned Subsidiary with Major Issues Still Undecided McDermott Will & Emery
Oct
22
2020
 Inventor Uses Abstention to Avoid Getting “Screwed” McDermott Will & Emery
Oct
15
2020
 Federal Circuit Restores Induced Infringement Verdict Against Teva McDermott Will & Emery
Oct
15
2020
 Fate of PTAB Judges and Decisions Now in Hands of Supreme Court Mintz
Oct
14
2020
 Supreme Court Deciding Constitutionality of PTAB Judge Appointments Sheppard, Mullin, Richter & Hampton LLP
Oct
12
2020
 Biogen v. EMD Serono – “A Nest of Limitations” Schwegman, Lundberg & Woessner, P.A.
Oct
8
2020
 Product-by-Process Analysis Applies to Method of Treatment Claims McDermott Will & Emery
Oct
8
2020
 One Claim Construction Error Is Enough to Trigger New Trial on Infringement McDermott Will & Emery
Oct
8
2020
 No Due Process Violation When New Panel Hears Substantive Arguments McDermott Will & Emery
Oct
7
2020
 Federal Circuit Orders Partial Dismissal of Voip-Pal’s IPR Challenged Claims Foley & Lardner LLP
Oct
6
2020
 Joinder to the Rescue: Federal Circuit holds that joinder of instituted IPRs does not result in estoppel under § 315(e) Mintz
Oct
6
2020
 Federal Circuit Finds Recombinant Polypeptide Anticipated By Native Polypeptide Foley & Lardner LLP
Sep
30
2020
 Ready, Fire, Aim - Picking the Correct Vehicle for Constitutional Challenges to Administrative Agency Decisions K&L Gates LLP
Sep
29
2020
 PTAB Waits as Supreme Court Considers Arthrex Certiorari Petitions Foley & Lardner LLP
Sep
29
2020
 Actual Definitions Can Help Avoid Erroneous Constructions of Patent Claims Squire Patton Boggs (US) LLP
Sep
29
2020
 Federal Circuit Finds Agreement To Agree Not Enforceable Foley & Lardner LLP
Sep
16
2020
 Full of Hot Air? PTAB Joinder Decisions Under § 315(c) Are Appealable McDermott Will & Emery
Sep
16
2020
 Logic to Modify: Even Deceptive Intent Does Not Bar Inventorship Correction McDermott Will & Emery
Sep
9
2020
 No Bite on Parties’ Unenforceable Agreement to Agree to Sell Apple Trees McDermott Will & Emery
Sep
9
2020
 Structural Limitations Are Not Met by Imaginary Demarcation Lines McDermott Will & Emery
Subscribe to Federal Circuit / U.S. Court of Spec. Jurisdiction
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters